Serial chitotriosidase measurements in sarcoidosis – Two to five year follow-up study
Chitotriosidase (CTO) is a human chitinolytic enzyme secreted by activated macrophages and polymorphonuclear neutrophils. Albeit not specific for sarcoidosis, it is increased in over 90% of patients with active disease. The aims of this study were to correlate CTO measurements with clinical assessme...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Harlander, Matevž [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2014 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
8 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report - Hung, Shuo-Wen ELSEVIER, 2021, Burlington, Mass |
|---|---|
| Übergeordnetes Werk: |
volume:108 ; year:2014 ; number:5 ; pages:775-782 ; extent:8 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.rmed.2014.02.002 |
|---|
| Katalog-ID: |
ELV028273133 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV028273133 | ||
| 003 | DE-627 | ||
| 005 | 20230623193030.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.rmed.2014.02.002 |2 doi | |
| 028 | 5 | 2 | |a GBVA2014015000030.pica |
| 035 | |a (DE-627)ELV028273133 | ||
| 035 | |a (ELSEVIER)S0954-6111(14)00059-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.52 |2 bkl | ||
| 100 | 1 | |a Harlander, Matevž |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Serial chitotriosidase measurements in sarcoidosis – Two to five year follow-up study |
| 264 | 1 | |c 2014 | |
| 300 | |a 8 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Chitotriosidase (CTO) is a human chitinolytic enzyme secreted by activated macrophages and polymorphonuclear neutrophils. Albeit not specific for sarcoidosis, it is increased in over 90% of patients with active disease. The aims of this study were to correlate CTO measurements with clinical assessment of sarcoidosis and to test CTO as a marker of sarcoidosis relapse. | ||
| 650 | 7 | |a Sarcoidosis |2 Elsevier | |
| 650 | 7 | |a Chitotriosidase |2 Elsevier | |
| 650 | 7 | |a Follow-up |2 Elsevier | |
| 700 | 1 | |a Salobir, Barbara |4 oth | |
| 700 | 1 | |a Zupančič, Mirjana |4 oth | |
| 700 | 1 | |a Dolenšek, Marija |4 oth | |
| 700 | 1 | |a Bavčar Vodovnik, Tanja |4 oth | |
| 700 | 1 | |a Terčelj, Marjeta |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Harcourt |a Hung, Shuo-Wen ELSEVIER |t Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report |d 2021 |g Burlington, Mass |w (DE-627)ELV009124330 |
| 773 | 1 | 8 | |g volume:108 |g year:2014 |g number:5 |g pages:775-782 |g extent:8 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.rmed.2014.02.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.52 |j Therapie |x Medizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 108 |j 2014 |e 5 |h 775-782 |g 8 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
m h mh |
|---|---|
| matchkey_str |
harlandermatevsalobirbarbarazupanimirjan:2014----:eilhttisdsmaueetisrodsswtfv |
| hierarchy_sort_str |
2014 |
| bklnumber |
44.52 |
| publishDate |
2014 |
| allfields |
10.1016/j.rmed.2014.02.002 doi GBVA2014015000030.pica (DE-627)ELV028273133 (ELSEVIER)S0954-6111(14)00059-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.52 bkl Harlander, Matevž verfasserin aut Serial chitotriosidase measurements in sarcoidosis – Two to five year follow-up study 2014 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Chitotriosidase (CTO) is a human chitinolytic enzyme secreted by activated macrophages and polymorphonuclear neutrophils. Albeit not specific for sarcoidosis, it is increased in over 90% of patients with active disease. The aims of this study were to correlate CTO measurements with clinical assessment of sarcoidosis and to test CTO as a marker of sarcoidosis relapse. Sarcoidosis Elsevier Chitotriosidase Elsevier Follow-up Elsevier Salobir, Barbara oth Zupančič, Mirjana oth Dolenšek, Marija oth Bavčar Vodovnik, Tanja oth Terčelj, Marjeta oth Enthalten in Harcourt Hung, Shuo-Wen ELSEVIER Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report 2021 Burlington, Mass (DE-627)ELV009124330 volume:108 year:2014 number:5 pages:775-782 extent:8 https://doi.org/10.1016/j.rmed.2014.02.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.52 Therapie Medizin VZ AR 108 2014 5 775-782 8 045F 610 |
| spelling |
10.1016/j.rmed.2014.02.002 doi GBVA2014015000030.pica (DE-627)ELV028273133 (ELSEVIER)S0954-6111(14)00059-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.52 bkl Harlander, Matevž verfasserin aut Serial chitotriosidase measurements in sarcoidosis – Two to five year follow-up study 2014 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Chitotriosidase (CTO) is a human chitinolytic enzyme secreted by activated macrophages and polymorphonuclear neutrophils. Albeit not specific for sarcoidosis, it is increased in over 90% of patients with active disease. The aims of this study were to correlate CTO measurements with clinical assessment of sarcoidosis and to test CTO as a marker of sarcoidosis relapse. Sarcoidosis Elsevier Chitotriosidase Elsevier Follow-up Elsevier Salobir, Barbara oth Zupančič, Mirjana oth Dolenšek, Marija oth Bavčar Vodovnik, Tanja oth Terčelj, Marjeta oth Enthalten in Harcourt Hung, Shuo-Wen ELSEVIER Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report 2021 Burlington, Mass (DE-627)ELV009124330 volume:108 year:2014 number:5 pages:775-782 extent:8 https://doi.org/10.1016/j.rmed.2014.02.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.52 Therapie Medizin VZ AR 108 2014 5 775-782 8 045F 610 |
| allfields_unstemmed |
10.1016/j.rmed.2014.02.002 doi GBVA2014015000030.pica (DE-627)ELV028273133 (ELSEVIER)S0954-6111(14)00059-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.52 bkl Harlander, Matevž verfasserin aut Serial chitotriosidase measurements in sarcoidosis – Two to five year follow-up study 2014 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Chitotriosidase (CTO) is a human chitinolytic enzyme secreted by activated macrophages and polymorphonuclear neutrophils. Albeit not specific for sarcoidosis, it is increased in over 90% of patients with active disease. The aims of this study were to correlate CTO measurements with clinical assessment of sarcoidosis and to test CTO as a marker of sarcoidosis relapse. Sarcoidosis Elsevier Chitotriosidase Elsevier Follow-up Elsevier Salobir, Barbara oth Zupančič, Mirjana oth Dolenšek, Marija oth Bavčar Vodovnik, Tanja oth Terčelj, Marjeta oth Enthalten in Harcourt Hung, Shuo-Wen ELSEVIER Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report 2021 Burlington, Mass (DE-627)ELV009124330 volume:108 year:2014 number:5 pages:775-782 extent:8 https://doi.org/10.1016/j.rmed.2014.02.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.52 Therapie Medizin VZ AR 108 2014 5 775-782 8 045F 610 |
| allfieldsGer |
10.1016/j.rmed.2014.02.002 doi GBVA2014015000030.pica (DE-627)ELV028273133 (ELSEVIER)S0954-6111(14)00059-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.52 bkl Harlander, Matevž verfasserin aut Serial chitotriosidase measurements in sarcoidosis – Two to five year follow-up study 2014 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Chitotriosidase (CTO) is a human chitinolytic enzyme secreted by activated macrophages and polymorphonuclear neutrophils. Albeit not specific for sarcoidosis, it is increased in over 90% of patients with active disease. The aims of this study were to correlate CTO measurements with clinical assessment of sarcoidosis and to test CTO as a marker of sarcoidosis relapse. Sarcoidosis Elsevier Chitotriosidase Elsevier Follow-up Elsevier Salobir, Barbara oth Zupančič, Mirjana oth Dolenšek, Marija oth Bavčar Vodovnik, Tanja oth Terčelj, Marjeta oth Enthalten in Harcourt Hung, Shuo-Wen ELSEVIER Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report 2021 Burlington, Mass (DE-627)ELV009124330 volume:108 year:2014 number:5 pages:775-782 extent:8 https://doi.org/10.1016/j.rmed.2014.02.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.52 Therapie Medizin VZ AR 108 2014 5 775-782 8 045F 610 |
| allfieldsSound |
10.1016/j.rmed.2014.02.002 doi GBVA2014015000030.pica (DE-627)ELV028273133 (ELSEVIER)S0954-6111(14)00059-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.52 bkl Harlander, Matevž verfasserin aut Serial chitotriosidase measurements in sarcoidosis – Two to five year follow-up study 2014 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Chitotriosidase (CTO) is a human chitinolytic enzyme secreted by activated macrophages and polymorphonuclear neutrophils. Albeit not specific for sarcoidosis, it is increased in over 90% of patients with active disease. The aims of this study were to correlate CTO measurements with clinical assessment of sarcoidosis and to test CTO as a marker of sarcoidosis relapse. Sarcoidosis Elsevier Chitotriosidase Elsevier Follow-up Elsevier Salobir, Barbara oth Zupančič, Mirjana oth Dolenšek, Marija oth Bavčar Vodovnik, Tanja oth Terčelj, Marjeta oth Enthalten in Harcourt Hung, Shuo-Wen ELSEVIER Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report 2021 Burlington, Mass (DE-627)ELV009124330 volume:108 year:2014 number:5 pages:775-782 extent:8 https://doi.org/10.1016/j.rmed.2014.02.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.52 Therapie Medizin VZ AR 108 2014 5 775-782 8 045F 610 |
| language |
English |
| source |
Enthalten in Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report Burlington, Mass volume:108 year:2014 number:5 pages:775-782 extent:8 |
| sourceStr |
Enthalten in Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report Burlington, Mass volume:108 year:2014 number:5 pages:775-782 extent:8 |
| format_phy_str_mv |
Article |
| bklname |
Therapie |
| institution |
findex.gbv.de |
| topic_facet |
Sarcoidosis Chitotriosidase Follow-up |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report |
| authorswithroles_txt_mv |
Harlander, Matevž @@aut@@ Salobir, Barbara @@oth@@ Zupančič, Mirjana @@oth@@ Dolenšek, Marija @@oth@@ Bavčar Vodovnik, Tanja @@oth@@ Terčelj, Marjeta @@oth@@ |
| publishDateDaySort_date |
2014-01-01T00:00:00Z |
| hierarchy_top_id |
ELV009124330 |
| dewey-sort |
3610 |
| id |
ELV028273133 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV028273133</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623193030.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.rmed.2014.02.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014015000030.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV028273133</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0954-6111(14)00059-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Harlander, Matevž</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Serial chitotriosidase measurements in sarcoidosis – Two to five year follow-up study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Chitotriosidase (CTO) is a human chitinolytic enzyme secreted by activated macrophages and polymorphonuclear neutrophils. Albeit not specific for sarcoidosis, it is increased in over 90% of patients with active disease. The aims of this study were to correlate CTO measurements with clinical assessment of sarcoidosis and to test CTO as a marker of sarcoidosis relapse.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Sarcoidosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chitotriosidase</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Follow-up</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Salobir, Barbara</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zupančič, Mirjana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dolenšek, Marija</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bavčar Vodovnik, Tanja</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Terčelj, Marjeta</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Harcourt</subfield><subfield code="a">Hung, Shuo-Wen ELSEVIER</subfield><subfield code="t">Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report</subfield><subfield code="d">2021</subfield><subfield code="g">Burlington, Mass</subfield><subfield code="w">(DE-627)ELV009124330</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:108</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:775-782</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.rmed.2014.02.002</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.52</subfield><subfield code="j">Therapie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">108</subfield><subfield code="j">2014</subfield><subfield code="e">5</subfield><subfield code="h">775-782</subfield><subfield code="g">8</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Harlander, Matevž |
| spellingShingle |
Harlander, Matevž ddc 610 bkl 44.52 Elsevier Sarcoidosis Elsevier Chitotriosidase Elsevier Follow-up Serial chitotriosidase measurements in sarcoidosis – Two to five year follow-up study |
| authorStr |
Harlander, Matevž |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV009124330 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 44.52 bkl Serial chitotriosidase measurements in sarcoidosis – Two to five year follow-up study Sarcoidosis Elsevier Chitotriosidase Elsevier Follow-up Elsevier |
| topic |
ddc 610 bkl 44.52 Elsevier Sarcoidosis Elsevier Chitotriosidase Elsevier Follow-up |
| topic_unstemmed |
ddc 610 bkl 44.52 Elsevier Sarcoidosis Elsevier Chitotriosidase Elsevier Follow-up |
| topic_browse |
ddc 610 bkl 44.52 Elsevier Sarcoidosis Elsevier Chitotriosidase Elsevier Follow-up |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
b s bs m z mz m d md v t b vt vtb m t mt |
| hierarchy_parent_title |
Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report |
| hierarchy_parent_id |
ELV009124330 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV009124330 |
| title |
Serial chitotriosidase measurements in sarcoidosis – Two to five year follow-up study |
| ctrlnum |
(DE-627)ELV028273133 (ELSEVIER)S0954-6111(14)00059-6 |
| title_full |
Serial chitotriosidase measurements in sarcoidosis – Two to five year follow-up study |
| author_sort |
Harlander, Matevž |
| journal |
Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report |
| journalStr |
Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2014 |
| contenttype_str_mv |
zzz |
| container_start_page |
775 |
| author_browse |
Harlander, Matevž |
| container_volume |
108 |
| physical |
8 |
| class |
610 610 DE-600 610 VZ 44.52 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Harlander, Matevž |
| doi_str_mv |
10.1016/j.rmed.2014.02.002 |
| dewey-full |
610 |
| title_sort |
serial chitotriosidase measurements in sarcoidosis – two to five year follow-up study |
| title_auth |
Serial chitotriosidase measurements in sarcoidosis – Two to five year follow-up study |
| abstract |
Chitotriosidase (CTO) is a human chitinolytic enzyme secreted by activated macrophages and polymorphonuclear neutrophils. Albeit not specific for sarcoidosis, it is increased in over 90% of patients with active disease. The aims of this study were to correlate CTO measurements with clinical assessment of sarcoidosis and to test CTO as a marker of sarcoidosis relapse. |
| abstractGer |
Chitotriosidase (CTO) is a human chitinolytic enzyme secreted by activated macrophages and polymorphonuclear neutrophils. Albeit not specific for sarcoidosis, it is increased in over 90% of patients with active disease. The aims of this study were to correlate CTO measurements with clinical assessment of sarcoidosis and to test CTO as a marker of sarcoidosis relapse. |
| abstract_unstemmed |
Chitotriosidase (CTO) is a human chitinolytic enzyme secreted by activated macrophages and polymorphonuclear neutrophils. Albeit not specific for sarcoidosis, it is increased in over 90% of patients with active disease. The aims of this study were to correlate CTO measurements with clinical assessment of sarcoidosis and to test CTO as a marker of sarcoidosis relapse. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| container_issue |
5 |
| title_short |
Serial chitotriosidase measurements in sarcoidosis – Two to five year follow-up study |
| url |
https://doi.org/10.1016/j.rmed.2014.02.002 |
| remote_bool |
true |
| author2 |
Salobir, Barbara Zupančič, Mirjana Dolenšek, Marija Bavčar Vodovnik, Tanja Terčelj, Marjeta |
| author2Str |
Salobir, Barbara Zupančič, Mirjana Dolenšek, Marija Bavčar Vodovnik, Tanja Terčelj, Marjeta |
| ppnlink |
ELV009124330 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth |
| doi_str |
10.1016/j.rmed.2014.02.002 |
| up_date |
2024-07-06T18:22:46.153Z |
| _version_ |
1803854981266145280 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV028273133</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623193030.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.rmed.2014.02.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014015000030.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV028273133</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0954-6111(14)00059-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Harlander, Matevž</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Serial chitotriosidase measurements in sarcoidosis – Two to five year follow-up study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Chitotriosidase (CTO) is a human chitinolytic enzyme secreted by activated macrophages and polymorphonuclear neutrophils. Albeit not specific for sarcoidosis, it is increased in over 90% of patients with active disease. The aims of this study were to correlate CTO measurements with clinical assessment of sarcoidosis and to test CTO as a marker of sarcoidosis relapse.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Sarcoidosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chitotriosidase</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Follow-up</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Salobir, Barbara</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zupančič, Mirjana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dolenšek, Marija</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bavčar Vodovnik, Tanja</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Terčelj, Marjeta</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Harcourt</subfield><subfield code="a">Hung, Shuo-Wen ELSEVIER</subfield><subfield code="t">Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report</subfield><subfield code="d">2021</subfield><subfield code="g">Burlington, Mass</subfield><subfield code="w">(DE-627)ELV009124330</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:108</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:775-782</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.rmed.2014.02.002</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.52</subfield><subfield code="j">Therapie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">108</subfield><subfield code="j">2014</subfield><subfield code="e">5</subfield><subfield code="h">775-782</subfield><subfield code="g">8</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.4007425 |